<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37437450</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-866X</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Seminars in arthritis and rheumatism</Title><ISOAbbreviation>Semin Arthritis Rheum</ISOAbbreviation></Journal><ArticleTitle>Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis.</ArticleTitle><Pagination><StartPage>152238</StartPage><MedlinePgn>152238</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semarthrit.2023.152238</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-0172(23)00080-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The VITAL trial of vitamin D supplementation suggested a possible protective effect for autoimmune diseases but uncertainties remain. We investigated potential causal effects of vitamin D on composite and individual autoimmune diseases using Mendelian randomization.</AbstractText><AbstractText Label="METHODS">We used data from 332,984 participants of the UK Biobank of whom 23,089 had at least one autoimmune disease defined using ICD code and/or self-report. Diseases were further considered in mechanistic subgroups driven by "autoimmunity" (n&#xa0;=&#xa0;12,774) or "autoinflammation" (n&#xa0;=&#xa0;11,164), then individually. We selected variants within gene regions implicated in vitamin D biology to generate a weighted genetic score. We performed population-wide analysis using the ratio method, then examined non-linear effects across five quantiles based on 25-hydroxycholecalciferol levels.</AbstractText><AbstractText Label="RESULTS">Genetically-predicted vitamin D was associated with lower risk of diseases in the autoinflammation group (OR 0.95 per 10&#xa0;ng/ml increase in 25-hydroxycholecalciferol; 95%CI 0.91-0.99; p&#xa0;=&#xa0;0.03) but not the autoimmunity group (OR 0.99; 95%CI 0.95-1.03; p&#xa0;=&#xa0;0.64) or combined. When considering individual diseases, genetically-predicted vitamin D was associated with lower risk of psoriasis (OR 0.91; 95%CI 0.85-0.97; p&#xa0;=&#xa0;0.005), the most common disease in the autoinflammation group, and suggestively with systemic lupus erythematosus (OR 0.84; 95%CI 0.69-1.02; p&#xa0;=&#xa0;0.08); results were replicated using data from independent studies. We found no evidence for a plausible non-linear relationship between vitamin D and any outcome.</AbstractText><AbstractText Label="CONCLUSIONS">We found genetic evidence to support a causal link between 25-hydroxycholecalciferol concentrations and psoriasis and systemic lupus erythematosus. These results have implications for potential disease prevention strategies, and the interpretation and design of vitamin D supplementation trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Sizheng Steven</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gjekmarkaj</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanaoka</LastName><ForeName>Haruyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgess</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, UK. Electronic address: sb452@medschl.cam.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>100114</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RG/13/13/30194</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RG/18/13/33946</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RE/18/1/34212</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BRC-1215-20014</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Semin Arthritis Rheum</MedlineTA><NlmUniqueID>1306053</NlmUniqueID><ISSNLinking>0049-0172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>P6YZ13C99Q</RegistryNumber><NameOfSubstance UI="D002112">Calcifediol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002112" MajorTopicYN="N">Calcifediol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune disease</Keyword><Keyword MajorTopicYN="N">Autoinflammation</Keyword><Keyword MajorTopicYN="N">Genetic instrumental variable</Keyword><Keyword MajorTopicYN="N">Psoriasis</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">UK Biobank</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>13</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37437450</ArticleId><ArticleId IdType="mid">EMS180734</ArticleId><ArticleId IdType="pmc">PMC7614794</ArticleId><ArticleId IdType="doi">10.1016/j.semarthrit.2023.152238</ArticleId><ArticleId IdType="pii">S0049-0172(23)00080-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400:733&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">36041475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11:754&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22387972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum. 2011;40:512&#x2013;531.:e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098920</ArticleId><ArticleId IdType="pubmed">21047669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791065</ArticleId><ArticleId IdType="pubmed">35082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, et al. The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016;167:1415&#x2013;1429.:e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5300907</ArticleId><ArticleId IdType="pubmed">27863252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, et al. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. PLoS Med. 2015;12:e1001866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549308</ArticleId><ArticleId IdType="pubmed">26305103</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, McDermott MF. A Proposed Classification of the Immunological Diseases. PLOS Medicine. 2006;3:e297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564298</ArticleId><ArticleId IdType="pubmed">16942393</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Aydin SZ, G&#xfc;l A, Mahr A, Direskeneli H. &#x2018;MHC-I-opathy&#x2019;-unified concept for spondyloarthritis and Beh&#xe7;et disease. Nat Rev Rheumatol. 2015;11:731&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">26526644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofianopoulou E, Kaptoge SK, Afzal S, Jiang T, Gill D, Gundersen TE, et al. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. The Lancet Diabetes Endocrinology. 2021;9:837&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600124</ArticleId><ArticleId IdType="pubmed">34717822</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian H, Mason AM, Liu C, Burgess S. Relaxing parametric assumptions for non-linear Mendelian randomization using a doubly-ranked stratification method. [cited 2023 Feb 23];2022 :2022.06.28.497930. doi: 10.1101/2022.06.28.497930v1. [Internet]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.28.497930v1</ArticleId><ArticleId IdType="pmc">PMC10343089</ArticleId><ArticleId IdType="pubmed">37390109</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S. Violation of the constant genetic effect assumption can result in biased estimates for non-linear Mendelian randomization. [cited 2023 Feb 23];2022 :2022.10.26.22280570. doi: 10.1101/2022.10.26.22280570v1. [Internet]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.26.22280570v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Access results. FinnGen;  [cited 2023 Feb 23].  [Internet] Available from: https://www.finngen.fi/en/access_results.</Citation></Reference><Reference><Citation>Revez JA, Lin T, Qiao Z, Xue A, Holtz Y, Zhu Z, et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun. 2020;11:1647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118120</ArticleId><ArticleId IdType="pubmed">32242144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas A, Wolf M. Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials. JAMA. 2019;322:1866&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31703117</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. New England Journal of Medicine. 2019;380:33&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6425757</ArticleId><ArticleId IdType="pubmed">30415629</ArticleId></ArticleIdList></Reference><Reference><Citation>Djouss&#xe9; L, Cook NR, Kim E, Bodar V, Walter J, Bubes V, et al. Supplementation With Vitamin D and Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization. Circulation. 2020;141:784&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054158</ArticleId><ArticleId IdType="pubmed">31709816</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert CM, Cook NR, Pester J, Moorthy MV, Ridge C, Danik JS, et al. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA. 2021;325:1061&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967086</ArticleId><ArticleId IdType="pubmed">33724323</ArticleId></ArticleIdList></Reference><Reference><Citation>Okereke OI, Reynolds CF, III, Mischoulon D, Chang G, Vyas CM, Cook NR, et al. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA. 2020;324:471&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403921</ArticleId><ArticleId IdType="pubmed">32749491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SH, Murata EM, Yu C, Danik J, Kotler G, Cook NR, et al. Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL) J Clin Endocrinol Metab. 2021;106:1377&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063236</ArticleId><ArticleId IdType="pubmed">33513226</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBoff MS, Murata EM, Cook NR, Cawthon P, Chou SH, Kotler G, et al. VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population. The Journal of Clinical Endocrinology Metabolism. 2020;105:2929&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365686</ArticleId><ArticleId IdType="pubmed">32492153</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBoff MS, Chou SH, Murata EM, Donlon CM, Cook NR, Mora S, et al. Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA-3 TriaL (VITAL) J Bone Miner Res. 2020;35:883&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217747</ArticleId><ArticleId IdType="pubmed">31923341</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. New England Journal of Medicine. 2022;387:299&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9716639</ArticleId><ArticleId IdType="pubmed">35939577</ArticleId></ArticleIdList></Reference><Reference><Citation>Orkaby AR, Dushkes R, Ward R, Djousse L, Buring JE, Lee IM, et al. Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial. JAMA Netw Open. 2022;5:e2231206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9471979</ArticleId><ArticleId IdType="pubmed">36098968</ArticleId></ArticleIdList></Reference><Reference><Citation>MacFarlane LA, Cook NR, Kim E, Lee IM, Iversen MD, Gordon D, et al. The Effects of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Chronic Knee Pain in Older US Adults: Results From a Randomized Trial. Arthritis Rheumatol. 2020;72:1836&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874905</ArticleId><ArticleId IdType="pubmed">32583982</ArticleId></ArticleIdList></Reference><Reference><Citation>Costenbader KH, MacFarlane LA, Lee IM, Buring JE, Mora S, Bubes V, et al. Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults. Clin Chem. 2019;65:1508&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6883134</ArticleId><ArticleId IdType="pubmed">31699704</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y, Giacomelli R, Azrielant S, Berardicurti O, Reynolds JA, Bruce IN. Vitamin D and systemic lupus erythematosus-The hype and the hope. Autoimmunity Reviews. 2018;17:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29108830</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae SC, Lee YH. Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization. Clin Rheumatol. 2018;37:2415&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">29799605</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>